Applied DNA Sciences (APDN) has issued an update.
Applied DNA Sciences, Inc. stockholders have given the green light for a reverse stock split, with the board deciding on a 1:20 ratio set to take effect on April 25, 2024. This consolidation means every 20 shares of existing common stock will merge into a single share, maintaining the current par value. No fractional shares will be issued; instead, they’ll be rounded up to whole shares. The change will be automatic for those with electronic shares, while paper certificates will be swapped for book-entry shares. The company’s stock will continue trading under the same Nasdaq ticker, “APDN,” with an updated CUSIP number. The reverse split also adjusts the terms for stock options, warrants, and incentive plans proportionally.
Find detailed analytics on APDN stock on TipRanks’ Stock Analysis page.
